Comprehensive analysis of receptor tyrosine kinase activation in human melanomas reveals autocrine signaling through IGF-1R

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Melanoma research

• Publication date

  2011-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CMR.0b013e328343a1d6PMID 21654344PMCID PMC3131461
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of oncogenes and growth factors in progressive melanoma-genesis.

  2008cited by this paper
• Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.

  2008cited by this paper
• Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.

  2008cited by this paper
• The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.

  2007cited by this paper
• Met-HGF/SF: tumorigenesis, invasion and metastasis.

  2007cited by this paper
• Human melanoma cells expressing V600E B-RAF are susceptible to IGF1R targeting by small interfering RNAs

  2006cited by this paper
• Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.

  2005cited by this paper
• RON, a Tyrosine Kinase Receptor Involved in Tumor Progression and Metastasis

  2005cited by this paper
• Synergistic inhibition of human melanoma proliferation by combination treatment with B-Raf inhibitor BAY43-9006 and mTOR inhibitor Rapamycin

  2005cited by this paper
• KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.

  2005cited by this paper
• Sequential Immune Escape and Shifting of T Cell Responses in a Long-Term Survivor of Melanoma 1

  2005cited by this paper
• RET tyrosine kinase signaling in development and cancer.

  2005cited by this paper
• Epidermal growth factor receptor pathway inhibitors.

  2005cited by this paper
• Tyrosine kinase receptors as attractive targets of cancer therapy.

  2004cited by this paper
• A Pooled Analysis of Eastern Cooperative Oncology Group and Intergroup Trials of Adjuvant High-Dose Interferon for Melanoma

  2004cited by this paper
• An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation.

  2003cited by this paper
• Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil

  2003cited by this paper
• Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction.

  2002cited by this paper
• IGF-I receptor signalling in transformation and differentiation

  2001cited by this paper
• Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

  2001cited by this paper
• Downregulation of E-cadherin and Desmoglein 1 by autocrine hepatocyte growth factor during melanoma development

  2001cited by this paper
• Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

  2001cited by this paper
• Insulin-like growth factor-1 induces survival and growth of biologically early melanoma cells through both the mitogen-activated protein kinase and beta-catenin pathways.

  2001cited by this paper
• Anti-apoptotic action of macrophage stimulating protein (MSP)

  2001cited by this paper
• Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and β-Catenin Pathways

  2001cited by this paper
• The n e w e n g l a n d j o u r n a l of m e d i c i n e

  2001cited by this paper
• Cross-talk between the proto-oncogenes Met and Ron

  2000cited by this paper
• Biological rationale for HER2/neu (c-erbB2) as a target for monoclonal antibody therapy.

  2000cited by this paper
• Melanomas with concordant loss of multiple melanocytic differentiation proteins: immune escape that may be overcome by targeting unique or undefined antigens

  2000cited by this paper
• Human melanoma progression in skin reconstructs : biological significance of bFGF.

  2000cited by this paper
• Autocrine and paracrine regulation by cytokines and growth factors in melanoma.

  2000cited by this paper
• Hepatocyte growth factor is an invasion/migration factor of rat urothelial carcinoma cells in vitro.

  1999cited by this paper
• Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).

  1999cited by this paper
• Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes

  1999cited by this paper
• Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes.

  1998cited by this paper
• Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).

  1998cited by this paper
• Malignant melanoma: modern black plague and genetic black box.

  1998cited by this paper
• Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target

  1998cited by this paper
• The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).

  1998cited by this paper
• Influence of Hepatocyte Growth Factor/Scatter Factor on the Metastatic Phenotype of B16 Melanoma Cells

  1998cited by this paper
• Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• Growth factors and melanomas.

  1996cited by this paper
• Activation of Mitogen-activated Protein (MAP) Kinase Pathway by Pervanadate, a Potent Inhibitor of Tyrosine Phosphatases*

  1996cited by this paper
• Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor.

  1994cited by this paper
• Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity.

  1994cited by this paper
• Autocrine and paracrine roles for growth factors in melanoma.

  1994cited by this paper
• Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression.

  1993cited by this paper
• Role of growth factors and their receptors in the development and progression of melanoma.

  1993cited by this paper
• Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor

  1992cited by this paper
• Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.

  1992cited by this paper
• Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth.

  1991cited by this paper
• Growth factors in melanoma

  1991cited by this paper
• The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.

  1989cited by this paper
• Basic fibroblast growth factor from human keratinocytes is a natural mitogen for melanocytes

  1988cited by this paper

• BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway

  2024cites this paper
• Therapeutic targeting of anoikis resistance in cutaneous melanoma metastasis

  2023cites this paper
• IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma

  2021cites this paper
• Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches

  2021cites this paper
• Structural Mechanisms of Store-Operated and Mitochondrial Calcium Regulation: Initiation Points for Drug Discovery

  2020cites this paper
• Phase I, open-label study of pasireotide in patients with BRAF-wild type and NRAS-wild type, unresectable and/or metastatic melanoma

  2018cites this paper
• Targeting growth hormone receptor in human melanoma cells attenuates tumor progression and epithelial mesenchymal transition via suppression of multiple oncogenic pathways

  2017influential citation
• A survey of membrane receptor regulation in valvular interstitial cells cultured under mechanical stresses

  2017cites this paper
• Unbalancing p53/Mdm2/IGF-1R axis by Mdm2 activation restrains the IGF-1-dependent invasive phenotype of skin melanoma

  2017cites this paper
• Insulin-like growth factor (IGF) axis in cancerogenesis.

  2017cites this paper
• Uncarboxylated Osteocalcin Induces Antitumor Immunity against Mouse Melanoma Cell Growth

  2017cites this paper
• Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma

  2017cites this paper
• A study on the involvement of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II /Fu Xiuqiong.

  2017cites this paper
• Recent developments in receptor tyrosine kinases targeted anticancer therapy

  2016cites this paper
• Unravelling molecular mechanisms underlying therapy resistance in cutaneous melanoma

  2016cites this paper
• The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma

  2016cites this paper
• Top-Accessed Article: UV Light Tanning as a Type of Substance-Related Disorder

  2016cites this paper
• PhosphoPath: Visualization of Phosphosite-centric Dynamics in Temporal Molecular Networks.

  2015cites this paper
• Systems Analysis of Adaptive Responses to MAP Kinase Pathway Blockade in BRAF Mutant Melanoma

  2015cites this paper
• miR-425 inhibits melanoma metastasis through repression of PI3K-Akt pathway by targeting IGF-1.

  2015cites this paper
• From membrane to nucleus: New roles and functions of SUMOylated IGF-1R and EGFR

  2015cites this paper
• Druggable targets in pediatric neurocutaneous melanocytosis: Molecular and drug sensitivity studies in xenograft and ex vivo tumor cell culture to identify agents for therapy.

  2015cites this paper
• A mechanistic study on the anti-melanoma action of quercetin

  2015cites this paper
• Aurora Kinases as Druggable Targets in Pediatric Leukemia: Heterogeneity in Target Modulation Activities and Cytotoxicity by Diverse Novel Therapeutic Agents

  2014cites this paper
• Metabotropic glutamate receptor 1 mediates melanocyte transformation via transactivation of insulin‐like growth factor 1 receptor

  2014cites this paper
• Towards combinatorial targeted therapy in melanoma: From pre-clinical evidence to clinical application (Review)

  2014influential citation
• Amuvatinib has cytotoxic effects against NRAS-mutant melanoma but not BRAF-mutant melanoma

  2014cites this paper
• NRAS mutant melanoma: biological behavior and future strategies for therapeutic management

  2013cites this paper
• Clinical Activity and Safety of Combination Therapy with Temsirolimus and Bevacizumab for Advanced Melanoma: A Phase II Trial (CTEP 7190/Mel47)

  2013cites this paper
• Evaluation of Tyro3 expression, Gas6-mediated Akt phosphorylation, and the impact of anti-Tyro3 antibodies in melanoma cell lines.

  2013cites this paper
• Metabotropic glutamate receptor 1 in human malignancies

  2013cites this paper
• MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab

  2013influential citation
• Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor

  2012cites this paper
• Ron receptor tyrosine kinase signaling as a therapeutic target

  2012cites this paper
• ADAMTS5 functions as an anti-angiogenic and anti-tumorigenic protein independent of its proteoglycanase activity.

  2012cites this paper
• Insulin-like growth factor-1 boosts the developing process of condylar hyperplasia by stimulating chondrocytes proliferation.

  2012cites this paper
• Potential role of human growth hormone in melanoma growth promotion.

  2012cites this paper
• Synthetic Lethal Screening with Small-Molecule Inhibitors Provides a Pathway to Rational Combination Therapies for Melanoma

  2012cites this paper
• Inhibition of human breast cancer Matrigel invasion by Streptolysin O activation of the EGF receptor ErbB1.

  2011cites this paper
• Potential Role of Human Growth Hormone in Melanoma Growth Promotion

  year unknowncites this paper
• A a R R R 2 2 2 0 0 0 1 1 1 2 2 2 Content

  year unknowncites this paper